Switzerland· 38219004
Creon 25'000, Hartkapseln
A multienzyme - lipase, protease etc product, registered in Switzerland by Viatris Pharma GmbH and dispensed under Swissmedic category D. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Multienzyme - lipase, protease etc is registered in 11 of 19 countries.
Countries holding a registration under ATC A09AA02 (multienzyme - lipase, protease etc), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Multienzyme - lipase, protease etc · ATC A09AA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- Viatris Pharma GmbH
- Country
- Switzerland (CH)
- ATC code
- A09AA02
- ATC class
- Multienzyme - Lipase, Protease etc
- Defined daily dose
- 240 TSD, FIP
- Swissmedic category
- D
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for multienzyme - lipase, protease etc.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Multienzyme - lipase, protease etc · interactions on record
20 records
- 20 moderate
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Calcium carbonateA02AC01moderate
- MagaldrateA02AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A09AA02
Multienzyme - lipase, protease etc, as other registers publish it.
- BelgiumAnkreta 10000 UAllgen Pharmaceuticals
- BelgiumAnkreta 25000 UAllgen Pharmaceuticals
- FinlandCombizymSankyo Pharma GmbH
- FinlandCombizym CompSankyo Pharma GmbH
- FinlandCombizym ForteSankyo Pharma GmbH
- SwitzerlandCombizym, DragéesBridging Pharma GmbH
- CanadaCOTAZYMORGANON CANADA INC.
- CanadaCOTAZYM ECS 20ORGANON CANADA INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/deb0d09f-49bb-417b-be6c-7a997cb459ef GET /v1/drugs/deb0d09f-49bb-417b-be6c-7a997cb459ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about multienzyme - lipase, protease etc.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.